Guillain-Barre syndrome

Most patients show continued disease progression for up to 2 weeks, followed by a plateau phase of 2 to 4 weeks, and then recovery of function. Patients should have follow-up within 2 weeks after the acute syndrome to evaluate for relapse, at which point plasma exchange can be considered. Thereafter, follow-up is every 4 to 6 weeks for 6 months, then to 6 months for 1 year, and then yearly.

Patients should continue to have access to physiotherapy and occupational therapy, and monitoring for psychological problems should be ongoing.